Through the strong correlation between PLR and Hb, it is suggested that “platelet-lymphocyte axis” may be the core inflammatory regulation pathway of MHD anemia, which provides a theoretical basis for targeted intervention (such as antiplatelet drugs or immunomodulators). This evidence concerns the gene GSTM1 and anemia (phenotype).